NOAEL Studies
Emollient
Isopropyl Palmitate NOAEL Studies
INCI: ISOPROPYL PALMITATE
CAS: 142-91-6
Raw No Observed Adverse Effect Level endpoint records grouped by source. This page does not render calculated Margin of Safety values.
NTP_ICE_skin_irritation 6 endpoints
| Source | Endpoint Type | Value | Unit | Species | Route | Duration | Study Type | Reference |
|---|---|---|---|---|---|---|---|---|
| NTP_ICE_skin_irritation | Positive reaction | 0 | % | Human | Dermal | - | In Vivo; Four-hour Human Patch Test | sheet=Data_invivo; excel_row=1864; Record_ID=skin_irritation_invivo_39; Data_Type=In Vivo; Mixture=Chemical; DTXSID=DTXSID9027104; Assay=Four-hour Human Patch Test; Endpoint=Positive reaction; Response=0; Response_Unit=%; Species=Human; Reference=Basketter et al. 2004; 15291823; 10.1111/j.0105-1873.2004.00385.x; URL_CompTox=https://comptox.epa.gov/dashboard/chemical/details/DTXSID9027104 |
| NTP_ICE_skin_irritation | Viability | 97.4 | % | - | Dermal | - | In Vitro; EpiDerm Irritation | sheet=Data_invitro; excel_row=6006; Record_ID=skin_irritation_invitro_641; Data_Type=In Vitro; Formulation_Name=Isopropyl palmitate; Concentration=99.8; Concentration_Units=%; Mixture=Chemical; DTXSID=DTXSID9027104; Assay=EpiDerm Irritation; Endpoint=Viability; Response=97.4; Response_Unit=%; Reference=Kandarova et al. 2005; 16185104; 10.1177/026119290503300408; URL_CompTox=https://comptox.epa.gov/dashboard/chemical/details/DTXSID9027104 |
| NTP_ICE_skin_irritation | Viability | 103.6 | % | - | Dermal | - | In Vitro; EpiDerm Irritation | sheet=Data_invitro; excel_row=6003; Record_ID=skin_irritation_invitro_646; Data_Type=In Vitro; Formulation_Name=Isopropyl palmitate; Concentration=99.8; Concentration_Units=%; Mixture=Chemical; DTXSID=DTXSID9027104; Assay=EpiDerm Irritation; Endpoint=Viability; Response=103.6; Response_Unit=%; Reference=Kandarova et al. 2005; 16185104; 10.1177/026119290503300408; URL_CompTox=https://comptox.epa.gov/dashboard/chemical/details/DTXSID9027104 |
| NTP_ICE_skin_irritation | Viability | 104.32 | % | - | Dermal | - | In Vitro; EpiSkin Irritation | sheet=Data_invitro; excel_row=6002; Record_ID=skin_irritation_invitro_639; Data_Type=In Vitro; Formulation_Name=Isopropyl palmitate; Concentration=90; Concentration_Units=%; Mixture=Chemical; DTXSID=DTXSID9027104; Assay=EpiSkin Irritation; Endpoint=Viability; Response=104.32; Response_Unit=%; Reference=Cotovio et al. 2005; 16185103; 10.1177/026119290503300403; URL_CompTox=https://comptox.epa.gov/dashboard/chemical/details/DTXSID9027104 |
| NTP_ICE_skin_irritation | Viability | 104.83 | % | - | Dermal | - | In Vitro; EpiSkin Irritation | sheet=Data_invitro; excel_row=6005; Record_ID=skin_irritation_invitro_640; Data_Type=In Vitro; Formulation_Name=Isopropyl palmitate; Concentration=90; Concentration_Units=%; Mixture=Chemical; DTXSID=DTXSID9027104; Assay=EpiSkin Irritation; Endpoint=Viability; Response=104.83; Response_Unit=%; Reference=Cotovio et al. 2005; 16185103; 10.1177/026119290503300403; URL_CompTox=https://comptox.epa.gov/dashboard/chemical/details/DTXSID9027104 |
| NTP_ICE_skin_irritation | Viability | 122.3 | % | - | Dermal | - | In Vitro; EpiDerm Irritation | sheet=Data_invitro; excel_row=6004; Record_ID=skin_irritation_invitro_648; Data_Type=In Vitro; Formulation_Name=Isopropyl palmitate; Concentration=99.8; Concentration_Units=%; Mixture=Chemical; DTXSID=DTXSID9027104; Assay=EpiDerm Irritation; Endpoint=Viability; Response=122.3; Response_Unit=%; Reference=Kandarova et al. 2005; 16185104; 10.1177/026119290503300408; URL_CompTox=https://comptox.epa.gov/dashboard/chemical/details/DTXSID9027104 |
NTP_ICE_skin_sensitization 3 endpoints
| Source | Endpoint Type | Value | Unit | Species | Route | Duration | Study Type | Reference |
|---|---|---|---|---|---|---|---|---|
| NTP_ICE_skin_sensitization | Incidence of positive responses | 0 | % | Human | Dermal | - | In Vivo; HPPT2020WIP; Human Maximization Test | sheet=Data_invivo; excel_row=5471; Record_ID=skin_sensitization_invivo_1273; Data_Type=In Vivo; Internal_Data_Source=HPPT2020WIP; Concentration=8.0; Concentration_Units=%; Mixture=Chemical; DTXSID=DTXSID9027104; Assay=Human Maximization Test; Endpoint=Incidence of positive responses; Response=0; Response_Unit=%; Species=Human; Route=Dermal; Reference=Epstein 1978: report to RIFM|Anonymous 1982; Not available; 10.1016/S0015-6264(82)80217-4; URL_CompTox=https://comptox.epa.gov/dashboard/chemical/details/DTXSID9027104 |
| NTP_ICE_skin_sensitization | Induction dose per skin area | 5400 | ug/cm2 | Human | Dermal | - | In Vivo; HPPT2020WIP; Human Maximization Test | sheet=Data_invivo; excel_row=5469; Record_ID=skin_sensitization_invivo_1273; Data_Type=In Vivo; Internal_Data_Source=HPPT2020WIP; Concentration=8.0; Concentration_Units=%; Mixture=Chemical; DTXSID=DTXSID9027104; Assay=Human Maximization Test; Endpoint=Induction dose per skin area; Response=5400; Response_Unit=ug/cm2; Species=Human; Route=Dermal; Reference=Epstein 1978: report to RIFM|Anonymous 1982; Not available; 10.1016/S0015-6264(82)80217-4; URL_CompTox=https://comptox.epa.gov/dashboard/chemical/details/DTXSID9027104 |
| NTP_ICE_skin_sensitization | Relative reliability score | 3 | unitless | Human | Dermal | - | In Vivo; HPPT2020WIP; Human Maximization Test | sheet=Data_invivo; excel_row=5475; Record_ID=skin_sensitization_invivo_1273; Data_Type=In Vivo; Internal_Data_Source=HPPT2020WIP; Concentration=8.0; Concentration_Units=%; Mixture=Chemical; DTXSID=DTXSID9027104; Assay=Human Maximization Test; Endpoint=Relative reliability score; Response=3; Response_Unit=Unitless; Species=Human; Route=Dermal; Reference=Epstein 1978: report to RIFM|Anonymous 1982; Not available; 10.1016/S0015-6264(82)80217-4; URL_CompTox=https://comptox.epa.gov/dashboard/chemical/details/DTXSID9027104 |
ToxValDB_GESTIS_DNEL 1 endpoint
| Source | Endpoint Type | Value | Unit | Species | Route | Duration | Study Type | Reference |
|---|---|---|---|---|---|---|---|---|
| ToxValDB_GESTIS_DNEL | DNEL systemic | =25.85 | mg/m3 | Human | inhalation | - | Toxicity Value | STORED_SOURCE_RECORD=https://clowder.edap-cluster.com/files/6543dd69e4b045b9ff7cd87e; RECORD_SOURCE_LEVEL=Extraction document; SOURCE_URL=https://www.dguv.de/ifa/gestis/gestis-dnel-liste/index-2.jsp; STUDY_GROUP=GESTIS DNEL:15632911:-:--; QC_CATEGORY=Programmatically extracted from structured data source; Source overall passed QC, but this record was not manually checked; QC_STATUS=not determined; SOURCE_HASH=ToxValhc_777c5d4ba1398e026289196cb2e85ba9 |
openFDA substances 4 endpoints
| Source | Endpoint Type | Value | Unit | Species | Route | Duration | Study Type | Reference |
|---|---|---|---|---|---|---|---|---|
| openFDA substances | FDA UNII substance identifier | 8CRQ2TH63M | UNII | - | - | - | chemical | {"approval_status":null,"molecular_formula":"C19H38O2","source_table":"substance_identifiers_fda","substance_class":"chemical","unii_code":"8CRQ2TH63M"} |
| openFDA substances | FDA UNII substance identifier | 8CRQ2TH63M | UNII | - | - | - | chemical | {"approval_status":null,"molecular_formula":"C19H38O2","source_table":"substance_identifiers_fda","substance_class":"chemical","unii_code":"8CRQ2TH63M"} |
| openFDA substances | FDA UNII substance identifier | 8CRQ2TH63M | UNII | - | - | - | chemical | {"approval_status":null,"molecular_formula":"C19H38O2","source_table":"substance_identifiers_fda","substance_class":"chemical","unii_code":"8CRQ2TH63M"} |
| openFDA substances | FDA UNII substance identifier | 8CRQ2TH63M | UNII | - | - | - | chemical | {"approval_status":null,"molecular_formula":"C19H38O2","source_table":"substance_identifiers_fda","substance_class":"chemical","unii_code":"8CRQ2TH63M"} |